期刊文献+

EB病毒EBNA1基因酵母工程菌的构建、表达及临床应用 被引量:2

Construction,expression and clinical application of Pichia pastoris for EBNA1 gene expression
原文传递
导出
摘要 目的建立能有效表达EB病毒核抗原1(EBNA1)基因的酵母工程菌株,并探讨EBNA1重组蛋白在鼻咽癌血清学诊断中的应用。方法以EBV DNA为模板,采用PCR法扩增目的基因片段EBNA1,与毕赤酵母表达载体pPICZaA连接,转化酵母菌GS115,甲醇诱导重组蛋白表达。表达产物经SDS-PAGE、免疫印迹法鉴定后,纯化目的蛋白作为包被抗原,制备ELISA试剂检测鼻咽癌患者和正常人群EBNA1-IgA抗体。结果在毕赤酵母菌中成功高效地表达了分泌型的EBNA1重组蛋白,相对分子质量为28 000,免疫印迹证实目的带有免疫原性,目的蛋白经纯化后作为包被抗原检测鼻咽癌患者和健康对照的敏感度和特异度分别为81.4%和95.8%。结论采用毕赤酵母系统高效分泌表达了EBNA1重组蛋白并对其在鼻咽癌血清筛选中的诊断价值进行了初步评估,获得了在鼻咽癌筛选中有一定诊断价值的pPICZa-EBNA1生产酵母工程菌株。 Objective To construct the pichia pastoris strain for effective expression of epstein - barr vires nuclear antigen 1 gene( EBNA1 ), and explore the application of recombinant EBNA1 protein in serological diagnosis of nasopharyngeal carcinoma (NPC). Methods DNA extracted from the B95 -8 cells was used as the templates in a polymerase chain reaction (PCR). EBNA1 759 bp ( aa 390 - aa 641 ) was generated and inserted into pPICZaA vector. The recombinant plasmids were transformed into GS115 yeast by electroporation. The yeast transformants were induced by methanol to express recombinant proteins. After i- dentification of SDS - PAGE and western blot, the synthesized recombinant protein was coated to mieroplate for detection of EBV - IgA antibody in NPC patients and normal persons by ELISA. Results Secretory recombinant EBNA1 protein was successful- ly expressed in the pichia pastoris. The molecular weight of products was approximately 28 000. The recombinant protein EBNA1 in the culture supernatant showed a good immtmoreactivity with IgA antibodies to EBV by Western blot. A novel ELISA was es- tablished using pichia pastoris - expressed EBNA1 protein. The sensitivity and specificity of EBNA1 as coating antigen in detec- tion of the serum specimens from NPC patients and normal persons were 81.4% and 95.8% respectively. Conehmion The se- cretory recombinant protein EBNA1 was highly exp.ressed in pichia pastoris. The diagnostic value of the recombinant protein in screening of NPC patients were primarily evaluated and the valuable pPICZa - EBNA1 yeast strain was obtained.
出处 《中国卫生检验杂志》 北大核心 2014年第17期2436-2439,共4页 Chinese Journal of Health Laboratory Technology
基金 教育部第44批留学回国人员科研启动基金(教外司留(2012)940)
关键词 鼻咽癌 EB病毒核抗原1 毕赤酵母 Nasopharyngeal carcinoma EBNA1 Pichia pastoris
  • 相关文献

参考文献8

  • 1Wong MM, Lye MS,Cheng HM, et al. Epstein - Barr virus serologyin the diagnosis of nasopharyngeal carcinoma[ J]. Asian Pac J Aller-gy Immunol,2005,23 (1) : 65 - 67.
  • 2Fachiroh J, Schouten T, Hariwiyanto B, et al. Molecular diversity ofEpstein - Barr virus IgG and IgA antibody responses in nasopharyn-geal carcinoma : a comparison of Indonesian, Chinese, and Europeansubjects[J]. J Infect Dis, 2004, 190(1): 53 -62.
  • 3Frappier L. Role of EBNA1 in NPC tumourigenesis [ J ]. SeminCancer Biol, 2012 , 22(2): 154-161.
  • 4Wang Y, Liu X,Xing X, et al. Variations of Epstein - Barr virusnuclear antigen 1 gene in gastric carcinomas and nasopharyngeal car-cinomas from Northern China[J]. Virus Res, 2010,147(2) : 258-264.
  • 5胡波,陈忠城,王东宁,李林.原核表达和制备EB病毒GST/BFRF3融合蛋白用于鼻咽癌的诊断筛查[J].中国病理生理杂志,2013,29(6):1147-1152. 被引量:4
  • 6Sanchez - Martinez D,Pattony JL,Stewart JA, et al. Detection ofEpstein - Barr virus specific antibodies by means of bacuclovirus -exposed EBV gpl25[ J]. J Virol Methods, 1995, 52( 1 -2) : 145-153.
  • 7胡波,李朝霞,盛平,李林.EB病毒VCA基因片段在毕赤酵母中的表达及临床应用[J].中华微生物学和免疫学杂志,2010,30(4):365-370. 被引量:7
  • 8Chen MR, Liu MY, Hsu SM, et al. Use of bacteriaily expressed EB-NA -1 protein cloned from a nasopharyngeal carcinoma ( NPC) bi-opsy as a screening test for NPC patients[ J]. J Med Virol, 2001, 64(1): 51 -57.

二级参考文献21

  • 1付涌水,江朝富,李树浓,徐霖,袁广卿,曹开源.抗-D抗体Fab段基因的克隆及其在大肠杆菌中的表达[J].中国病理生理杂志,2006,22(1):152-155. 被引量:2
  • 2Thorley-Lawson D.EBV the prototypical human tumor virus-just how bad is it? J Allergy Clin Immunol,2005,116(2):251-261 ; quiz 262.
  • 3Fields BN,Knipe DM,Chanock RM,et al(eds).Virology.New York:Raven Press,USA.1990:1921-1957.
  • 4Cheng W,Chan K,Chen H,et al.Assessing the risk of nasopharyngeal carcinoma on the basis of EBV Antibody spectrum.Int J Cancer,2002,97(4):489-492.
  • 5Hsu M,Hsu W,Sheen T,et al.Specific IgA antibodies to recombinant early and nuclear antigens of Epstein-Barr virus in nusopharyngeal carcinoma.Clin Otolaryngol Allied Sci,2001,26 (4):334-338.
  • 6Karray H,Ayadi W,Fki L,et al.Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.J Med Virol,2005,75(4):593-602.
  • 7Nystad T,Myrmel H.Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-,VCA IgM-and EBNA-1-antibodies and suspected infectious mononucleosis.J Clin Virol,2007,38(4):292-297.
  • 8Van Grunsven W,Spaan W,Middeldorp J.Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein.J Infect Dis,1994,170 (1):13-19.
  • 9Hinderer W,Lang D,Rothe M,et al.Serodiagnosis of EpsteinBarr vires infection by using recombinant viral capsid antigen fragments and autolagous gene fusion.J Clin Microbiol,1999,37 (10):3239-3244.
  • 10Wong M, Lye M, Cheng H, et al. Epstein-Barr virus serology in the diagnosis of nasopharyngeal carcinoma [J] . Asian Pac J Allergy Immunol, 2005, 23 (1 ) : 65-67.

共引文献8

同被引文献19

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部